Gotto, Geoffrey, et al. “Real-World Evidence in Patient-Reported Outcomes (PROs) of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated With Abiraterone Acetate + Prednisone (AA+P) across Canada: Final Results of COSMiC”. Canadian Urological Association Journal, vol. 14, no. 12, June 2020, pp. E616-20, doi:10.5489/cuaj.6388.